Immunoregulation of Shenqi Fuzheng Injection Combined with Chemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis

Background. Immunosuppression is a well-recognised complication of chemotherapy in cancer patients. We assemble the clinical evidence that SQI, an adjuvant drug for lung cancer and gastric cancer which was widely prescribed in China, interventions could increase objective tumour response and regulat...

詳細記述

保存先:
書誌詳細
出版年:Evid Based Complement Alternat Med
主要な著者: Yang, Yang, Ting, Wang, Xiao, Liu, Shufei, Fu, Wangxiao, Tan, Xiaoying, Wang, Xiumei, Gao, Boli, Zhang
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 2017
主題:
Review Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5244024/
https://ncbi.nlm.nih.gov/pubmed/28154607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5121538
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料